postmenopausal osteoporosis

Conclusion RFLP of ER gene associated with BMD in postmenopausal healthy women and this might explain the cause of postmenopausal osteoporosis in Chinese women.

结论ER基因RFLP与绝经后妇女BMD有关，此即为中国妇女绝经后骨质疏松症发病的原因。

Postmenopausal osteoporosis ( PMOF ) is the common disease, frequently-occurring disease after menopause.

绝经后骨质疏松症 ( PMOP ) 是绝经后妇女常见病 、 多发病.

Changes of plasma intact parathormone in patients with postmenopausal osteoporosis

绝经后骨质疏松患者的全段甲状旁腺素变化及其意义

Evaluation on the effect of postmenopausal middle-old aged osteoporosis women's health education

绝经后中老年女性骨质疏松症患者健康教育效果评价

SPACE BLOOD STASIS AND IT'S COUNTERMEASURE Postmenopausal Osteoporosis and Blood Stasis

航天血淤症及其防护措施绝经后骨质疏松症与血瘀

Treatment of Postmenopausal Osteoporosis with Decoction of Kidney-and Spleen-strengthening and Blood Circulation-activating: A Report of 33 Cases

补肾健脾活血汤治疗绝经后骨质疏松症33例

A comparison of DXA, QCT and SPA for diagnosis of osteoporosis in postmenopausal women

DXA、QCT和SPA方法测量47例绝经后妇女骨质疏松症的比较

Methods Seventy-three postmenopausal osteoporosis women and 61 postmenopausal healthy women were enrolled.

骨质疏松症73例，绝经后健康女性61例作对照组。

A case-control study on ER gene polymorphisms and postmenopausal osteoporosis in Southern Chinese women

ER基因多态性与中国南方妇女绝经后骨质疏松症的病例-对照研究

Conclusion The Chinese drugs were effective in preventing and treating postmenopausal osteoporosis by means of inhibiting bone resorption and bone transformation efficiency through its sex hormone actions.

结论补肾益气活血中药通过其性激素样作用来抑制骨吸收和骨转化率，防治绝经后骨质疏松。

Effect of embedding thread at Shenshu ( BL 23) on clinical pain of postmenopausal osteoporosis

肾俞埋线对绝经后骨质疏松症临床疼痛的影响

To explore the therapeutic effect and mechanism of Jiangu granule ( JGG ) on postmenopausal osteoporosis.

目的探索健骨 冲剂 对绝经后骨质疏松症疗效的作用机制.

Elcatonin in treatment of backache due to senile and postmenopausal osteoporosis

依降钙素治疗老年性或绝经后骨质疏松引起的腰背痛

Conclusion: From the Perspective of literature quality, scientific conclusion for clinical therapeutic effect of the method for reinforcing the kidney and replenishing vital essence on postmenopausal osteoporosis has not attained yet, and more SR study literature of high quality is needed.

结论：从研究文献质量看，尚不能对补肾益精法治疗绝经后骨质疏松症的临床疗效作出科学的结论，需要更多高质量的系统评价（SR）研究文献加以证实。

AIM : To observe the clinical effects of alfacalcidol the treatment of postmenopausal osteoporosis.

目的: 观察阿法骨化醇治疗绝经后骨质疏松症的疗效.

Aim: to observe the clinical effects of alfacalcidol the treatment of postmenopausal osteoporosis.

目的：观察阿法骨化醇治疗绝经后骨质疏松症的疗效。

Clinical effect of HRT combined with alendronate on postmenopausal osteoporosis

激素替代疗法联合阿仑膦酸钠治疗绝经后骨质疏松的临床研究

Effect of total coumarins from dried fruits of cnidium monnieri on prevention of postmenopausal osteoporosis

蛇床子总香豆素预防绝经后骨质疏松的作用